Loading news...
Loading news...
Illimis Therapeutics raised $41.8M Series B venture round, led by Yohan Kim.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
DSC InvestmentLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Investment Bank | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Investment Bank | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$41.8M
Top Valuation
-
Illimis Therapeutics raised $41.8M in a Series B round.
The round was announced on 07/14/25.
The round was led by Yohan Kim.